Hospital Mater Dei (MATD3) Q1 2025 earnings summary

Executive summary

• Achieved record operational and financial results for the quarter ended March 31, 2025, with net revenue reaching BRL 499.3 million and strong performance across units, supported by network expansion and AI-driven solutions.

• Extraordinary dividend of BRL 25.3 million (BRL 0.0745 per share) approved, reflecting robust cash generation and financial health, with payment by May 31, 2025.

• Fitch reaffirmed AA+ (bra) rating, highlighting resilience in operational cash flow and a conservative financial profile.

• Operational efficiency improved, with occupancy rate near 80% and cost dilution maintained despite sector challenges.

• AI solutions (A3Data, CotAI) contributed to revenue and operational improvements, generating over BRL 100 million in revenue in 8 months.

Financial highlights

• Net revenue reached BRL 499.3 million, up 2.4% year-over-year and 2.5% sequentially.

• Adjusted EBITDA was BRL 109 million, with margin improving to 22.4% (+3.4pp year-over-year).

• Net profit reached BRL 20.2 million, up 148% sequentially but down 37% year-over-year.

• Operational costs reduced as a percentage of revenue, with ongoing cost control efforts.

• Cash and equivalents stood at BRL 675 million at quarter-end.

Outlook and guidance

• Expectation of continued margin improvement and revenue growth, with net leverage projected to remain below 2.5x.

• Focus on operational efficiency, digital transformation, and working capital management.